Chemetall Unveils Permatreat 1903 for Treating Aluminum Can Ends

Chemetall, a unit of Rockwood Holdings, Inc. (NYSE: ROC) and a leading producer of specialty chemicals, has launched Permatreat RPT 1903 for the chemical treatment for aluminum can ends that will be a major contributor in making the manufacturing process of cans easier and more cost-effective versus traditional systems.

Aluminum cans are made from two pieces—the main can body and the can end. The metal used for can ends is a different aluminum alloy from the stock used for the can body and therefore has to be more resistant to corrosion, thus requiring a surface pre-treatment. Until the introduction of Permatreat 1903, the accepted technology for treating the can ends was causing intensive handling efforts and complicated process adaptations, especially in the use and the treatment of process materials.

“Chemetall has always been at the forefront of surface treatment technology,” said Joris Merckx, managing director of Chemetall Surface Treatment. “We strove to leverage our world class R&D in surface treatment technology to find a solution that would ensure safety and match, if not outperform, the existing, accepted technology. Backed by years of operational testing, the Permatreat 1903 not only provides an easier alternative to the traditional process, but offers additionally higher performance with regard to adhesion and corrosion.”

In addition to its safety aspects, the higher performance of Permatreat 1903 offers:

  • Versatility: it can be used as either a conventional dip process or as a no-rinse pre-treatment;
  • Flexibility: it has a great tolerance to changes in operating conditions and excellent results obtained with a wide variety of lacquer systems;
  • Ease of testing and program control.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.